IN2014DN01468A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN01468A IN2014DN01468A IN1468DEN2014A IN2014DN01468A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A IN 1468DEN2014 A IN1468DEN2014 A IN 1468DEN2014A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A
- Authority
- IN
- India
- Prior art keywords
- oligosaccharide
- composition
- infants
- mixture
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Pediatric Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185600 | 2011-10-18 | ||
| PCT/EP2012/070281 WO2013057049A1 (en) | 2011-10-18 | 2012-10-12 | Composition for use in brain growth and/or cognitive and/or psychomotor development |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN01468A true IN2014DN01468A (pt) | 2015-05-22 |
Family
ID=47019022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1468DEN2014 IN2014DN01468A (pt) | 2011-10-18 | 2012-10-12 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20140271562A1 (pt) |
| EP (2) | EP2775852B1 (pt) |
| CN (1) | CN103889238B (pt) |
| AU (1) | AU2012325060B2 (pt) |
| BR (1) | BR112014008944B1 (pt) |
| CL (1) | CL2014000759A1 (pt) |
| ES (1) | ES2601891T3 (pt) |
| IN (1) | IN2014DN01468A (pt) |
| MX (1) | MX350435B (pt) |
| MY (1) | MY170185A (pt) |
| PL (1) | PL2775852T3 (pt) |
| PT (1) | PT2775852T (pt) |
| RU (1) | RU2607458C2 (pt) |
| WO (1) | WO2013057049A1 (pt) |
| ZA (1) | ZA201403591B (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011005681A1 (en) | 2009-07-06 | 2011-01-13 | Children's Hospital Medical Center | Inhibiting inflammation with milk oligosaccharides |
| DK2708147T3 (da) | 2012-09-14 | 2020-05-18 | Abbott Lab | Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose |
| EP2708145B1 (en) | 2012-09-14 | 2016-05-04 | Abbott Laboratories | Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals |
| EP2880993A1 (en) * | 2013-12-04 | 2015-06-10 | Abbott Laboratories | Method of achieving memory and learning improvement by the administration of sialic acid |
| EP3082473A2 (en) * | 2013-12-19 | 2016-10-26 | Nestec S.A. | Nutritional composition to reduce metabolic stress in infants |
| US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| FR3020949B1 (fr) * | 2014-05-16 | 2018-02-09 | Ecole Normale Superieure De Lyon | Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition |
| US10328091B2 (en) | 2014-10-31 | 2019-06-25 | Nestec S.A. | Composition comprising Fut2-dependent oligosaccharides and Lacto-N-neotetraose for use in promoting brain development and cognition |
| WO2016086151A1 (en) * | 2014-11-26 | 2016-06-02 | Abbott Laboratories | Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic |
| WO2016145628A1 (en) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprising siallyllactose for use in enhancing learning skills and memory function |
| WO2016176484A1 (en) | 2015-04-28 | 2016-11-03 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
| CN107847509B (zh) * | 2015-08-04 | 2021-06-01 | 雀巢产品有限公司 | 具有2FL和LNnT的营养组合物 |
| PT3389404T (pt) | 2015-12-15 | 2020-01-14 | Nestle Sa | Mistura de hmos |
| AU2017213085B2 (en) * | 2016-01-26 | 2021-07-01 | Société des Produits Nestlé S.A. | Compositions comprising 2FL and LNnT to control food intake and growth in infants or young children |
| CN108495638A (zh) * | 2016-01-26 | 2018-09-04 | 雀巢产品技术援助有限公司 | 用于婴儿或幼儿以预防日后的肥胖或相关的并存病并促进健康生长的包含唾液酸化低聚糖的组合物 |
| EP3443969B1 (en) * | 2016-04-13 | 2021-12-22 | Meiji Co., Ltd. | Use of bifidobacteria for improving developmental quotient in neonates |
| CA3030809A1 (en) | 2016-07-28 | 2018-02-01 | Fonterra Co-Operative Group Limited | Sialyloligosaccharide product and process |
| WO2018204670A1 (en) | 2017-05-04 | 2018-11-08 | The Board Of Trustees Of The Leland Stanford Junior University | Neurodevelopment-promoting food compositions and kits, systems and methods related thereto |
| US11872238B2 (en) | 2017-05-24 | 2024-01-16 | Societe Des Produits Nestle S.A. | Nutritional composition for use to enhance attention and/or reduce impulsivity |
| AU2018295414A1 (en) * | 2017-07-07 | 2020-01-16 | Societe Des Produits Nestle S.A. | Human milk fortifier |
| US20200281245A1 (en) * | 2017-07-07 | 2020-09-10 | Societe Des Products Nestle S.A | Human milk fortifier |
| RU2698564C1 (ru) * | 2019-01-09 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев |
| AU2021391849A1 (en) | 2020-12-04 | 2023-05-18 | Société des Produits Nestlé S.A. | Stable aqueous composition for preterm to promote early postnal growth |
| KR102570073B1 (ko) * | 2022-11-17 | 2023-08-24 | (주)에이피테크놀로지 | 2'-푸코실락토오스를 포함하는 치매 개선 또는 치료용조성물 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0481038B1 (en) | 1990-04-16 | 2002-10-02 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US20040048926A1 (en) * | 2002-03-15 | 2004-03-11 | Hoffman Dennis Robert | Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months |
| PL1638416T3 (pl) * | 2003-06-23 | 2013-09-30 | Nestec Sa | Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej |
| US20070031537A1 (en) * | 2003-06-23 | 2007-02-08 | Marie-Cristene Secretin | Infant or follow-on formula |
| CA2520043C (en) * | 2003-06-30 | 2009-09-01 | Clasado Inc. | Novel galactooligosaccharide composition and the preparation thereof |
| US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
| CA2641842A1 (en) * | 2006-02-10 | 2007-08-16 | Nestec S.A. | Oligosaccharide mixture |
| US9005682B2 (en) * | 2006-03-07 | 2015-04-14 | Nestec S.A. | Synbiotic mixture |
| US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| AU2008328864B2 (en) * | 2007-11-26 | 2014-06-19 | Société des Produits Nestlé S.A. | Age-tailored nutrition system for infants |
| AU2010233770A1 (en) | 2009-04-07 | 2011-10-27 | Glycom A/S | Novel method for the synthesis of a trisaccharide |
| EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
| EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| EP2258218A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| CN102481323A (zh) * | 2009-07-31 | 2012-05-30 | 雀巢产品技术援助有限公司 | 含有益生菌和所选营养物的用于母乳喂养的婴幼儿或宠物的营养组合物 |
| CN105330705A (zh) * | 2010-02-19 | 2016-02-17 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
| EP2404507A1 (en) | 2010-07-08 | 2012-01-11 | Nestec S.A. | Array of age-tailored nutritional formula with optimum fat content |
| BR112013031086A2 (pt) * | 2011-06-08 | 2016-11-29 | Nestec Sa | composições nutricionais tendo componentes de membrana de glóbulo de gordura de leite exógenos |
-
2012
- 2012-10-12 CN CN201280051291.6A patent/CN103889238B/zh active Active
- 2012-10-12 EP EP12772784.0A patent/EP2775852B1/en active Active
- 2012-10-12 ES ES12772784.0T patent/ES2601891T3/es active Active
- 2012-10-12 PL PL12772784T patent/PL2775852T3/pl unknown
- 2012-10-12 MX MX2014004716A patent/MX350435B/es active IP Right Grant
- 2012-10-12 WO PCT/EP2012/070281 patent/WO2013057049A1/en active Application Filing
- 2012-10-12 PT PT127727840T patent/PT2775852T/pt unknown
- 2012-10-12 RU RU2014119844A patent/RU2607458C2/ru active
- 2012-10-12 AU AU2012325060A patent/AU2012325060B2/en not_active Withdrawn - After Issue
- 2012-10-12 US US14/352,236 patent/US20140271562A1/en not_active Abandoned
- 2012-10-12 MY MYPI2014700417A patent/MY170185A/en unknown
- 2012-10-12 IN IN1468DEN2014 patent/IN2014DN01468A/en unknown
- 2012-10-12 EP EP16174616.9A patent/EP3095331A1/en not_active Withdrawn
- 2012-10-12 BR BR112014008944-2A patent/BR112014008944B1/pt active IP Right Grant
-
2014
- 2014-03-27 CL CL2014000759A patent/CL2014000759A1/es unknown
- 2014-05-16 ZA ZA2014/03591A patent/ZA201403591B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140271562A1 (en) | 2014-09-18 |
| ES2601891T3 (es) | 2017-02-16 |
| MX350435B (es) | 2017-09-06 |
| CN103889238B (zh) | 2017-10-13 |
| BR112014008944B1 (pt) | 2020-09-15 |
| EP3095331A1 (en) | 2016-11-23 |
| AU2012325060B2 (en) | 2015-11-19 |
| AU2012325060A1 (en) | 2014-03-13 |
| WO2013057049A1 (en) | 2013-04-25 |
| EP2775852A1 (en) | 2014-09-17 |
| RU2607458C2 (ru) | 2017-01-10 |
| CN103889238A (zh) | 2014-06-25 |
| PT2775852T (pt) | 2016-11-08 |
| CL2014000759A1 (es) | 2014-08-22 |
| MX2014004716A (es) | 2015-02-05 |
| PL2775852T3 (pl) | 2017-02-28 |
| MY170185A (en) | 2019-07-09 |
| RU2014119844A (ru) | 2015-11-27 |
| EP2775852B1 (en) | 2016-08-17 |
| BR112014008944A2 (pt) | 2017-05-02 |
| ZA201403591B (en) | 2016-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN01468A (pt) | ||
| MY166016A (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
| MX2014004719A (es) | Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal. | |
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| MY173726A (en) | Synbiotics combination for brain improvement | |
| MX2014004722A (es) | Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea. | |
| MX2013011835A (es) | Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas. | |
| NZ613165A (en) | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof | |
| HK1198545A1 (en) | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof | |
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| PH12017500387A1 (en) | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition | |
| MX2015007584A (es) | Triheptanoina para el tratamiento de la deficiencia del transportador de glucosa 1. | |
| BR112012023328A2 (pt) | composições nutricionais | |
| WO2013049519A3 (en) | Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols | |
| MX2014004709A (es) | Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio. | |
| MX2013013512A (es) | Alimento medico para deterioro cognitivo. | |
| PH12016500690A1 (en) | Probiotic stabilization | |
| MX347541B (es) | Analogos de acido sialico. | |
| WO2011088209A3 (en) | 1-deoxy analogs of vitamin d-related compounds | |
| NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
| MX2013015419A (es) | Dha y epa en la reduccion de estres oxidante. | |
| PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants | |
| MX358142B (es) | Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones. | |
| GB201209344D0 (en) | Omega-6 enriched pufa phospholipids | |
| PL401911A1 (pl) | Zastosowanie preparatu o wlasciwosciach immunoregulatorowych |